Recent developments in hormone delivery systems
作者： Lee P. Shulman , Anita L. Nelson , Philip D. Darney
DOI: 10.1016/J.AJOG.2004.01.064
关键词:
摘要: Women who want safe, effective contraception have many more options than they did only a few years ago. Each option must be weighed carefully according to the needs and lifestyle of each particular woman. One method that provides long-term convenience with side-effect profile is comparable oral contraceptives once-a-month injectable contraceptive containing 25 mg medroxyprogesterone acetate 5 estradiol cypionate. Another levonorgestrel-releasing intrauterine system offers pregnancy prevention for years. Finally, hormonal implants release low doses progestins been used 30 by total 10 million women, easier-to-use will soon available.
elsevier.com
sci-hub.se 参考文章(47)
Eilers Gm, Swanson Tk, Women's satisfaction with Norplant as compared with oral contraceptives. Journal of Family Practice. ,vol. 38, pp. 596- 600 ,(1994)
W.S. Peart, T.M. Andrews, J.I.S. Robertson, CARCINOID SYNDROME The Lancet. ,vol. 277, pp. 577- 578 ,(1961) , 10.1016/S0140-6736(61)92247-4
James Trussell, Barbara Vaughan, Contraceptive Failure, Method-Related Discontinuation and Resumption of Use: Results from the 1995 National Survey of Family Growth Family Planning Perspectives. ,vol. 31, pp. 64- ,(1999) , 10.2307/2991641
P. Lahteenmaki, M. Haukkamaa, J. Puolakka, U. Riikonen, S. Sainio, J. Suvisaari, C. G. Nilsson, A. Prentice, Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ. ,vol. 316, pp. 1122- 1126 ,(1998) , 10.1136/BMJ.316.7138.1122
Stanley K. Henshaw, Unintended Pregnancy in the United States Family Planning Perspectives. ,vol. 30, pp. 24- 46 ,(1998) , 10.2307/2991522
J. Huber, Pharmacokinetics of Implanon. An integrated analysis. Contraception. ,vol. 58, pp. 85- ,(1998) , 10.1016/S0010-7824(98)00120-6
R. S. French, F. M. Cowan, D. Mansour, J. P. T. Higgins, A. Robinson, T. Procter, S. Morris, J. Guillebaud, Levonorgestrel-releasing (20 μg/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives British Journal of Obstetrics and Gynaecology. ,vol. 107, pp. 1218- 1225 ,(2000) , 10.1111/J.1471-0528.2000.TB11610.X
JUHANI TOIVONEN, TAPANI LUUKKAINEN, HANNU ALLONEN, Protective Effect of Intrauterine Release of Levonorgestrel on Pelvic Infection: Three Years' Comparative Experience of Levonorgestrel- and Copper-releasing Intrauterine Devices Obstetrics & Gynecology. ,vol. 77, pp. 261- 264 ,(1991) , 10.1097/00006250-199102000-00019
Amaju Ikomi, Eric F Pepra, Efficacy of the levonorgestrel intrauterine system in treating menorrhagia: actualities and ambiguities. Journal of Family Planning and Reproductive Health Care. ,vol. 28, pp. 99- 100 ,(2002) , 10.1783/147118902101196063
Tapani Luukkainen, Hannu Allonen, Maija Haukkamaa, Pekka Lähteenmäki, Carl Gustaf Nilsson, Juhani Toivonen, Five years' experience with levonorgestrel-releasing IUDs. Contraception. ,vol. 33, pp. 139- 148 ,(1986) , 10.1016/0010-7824(86)90080-6